| Mrs Trinidad Bridge, LPN | |
|
2909 S. 10th Avenue, Caldwell, ID 83605 | |
| (208) 454-2766 | |
| Not Available |
| Full Name | Mrs Trinidad Bridge |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2909 S. 10th Avenue, Caldwell, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578950168 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN-8693 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Trinidad Bridge, LPN Po Box 245, Kuna, ID 83634-0245 Ph: (208) 859-6473 | Mrs Trinidad Bridge, LPN 2909 S. 10th Avenue, Caldwell, ID 83605 Ph: (208) 454-2766 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
Many patients with Parkinson's Disease (PD) develop mild cognitive impairment (MCI) or dementia. Identifying biomarkers for cognitive impairment could be instrumental in facilitating both early diagnosis of MCI and developing new cognitive-enhancing treatments. New research published in the Journal of Parkinson's Disease indicates that lower concentrations of α-synuclein in cerebrospinal fluid (CSF) is associated with reduced performance on several cognitive tests.
A new cardiac CT technique, prospective gated 64-channel cardiac CT, has a significantly lower radiation dose and produces CT coronary angiograms with better image quality when compared with the standard retrospective ECG gating, according to a recent study conducted by researchers at the University of Washington in Redmond, WA.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces that the Food and Drug Administration has granted Fast Track designation to the GFT505 development program in NASH, with effect from February 14, 2014.
› Verified 8 days ago
Andrea Marie Gentry, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4521 Thomas Jefferson St, Caldwell, ID 83605 Phone: 208-454-4820 Fax: 208-454-4859 | |
Ben Ferro, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4521 Thomas Jefferson St, Caldwell, ID 83605 Phone: 208-454-4820 | |
Mrs. Wyndi M Stevens-hill, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4521 Thomas Jefferson St, Caldwell, ID 83605 Phone: 208-454-4820 Fax: 208-454-4859 | |
Melina Guzman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4521 Thomas Jefferson St, Caldwell, ID 83605 Phone: 208-454-4820 Fax: 208-454-4859 | |
Mrs. Lori Ann Akers, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4521 Thomas Jefferson St, Caldwell, ID 83605 Phone: 208-454-4820 Fax: 208-454-4859 | |
Ann Elizabeth Ortega, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4521 Thomas Jefferson St, Caldwell, ID 83605 Phone: 208-454-4820 Fax: 208-454-4859 |